Respiratory Market Research Reports 2026 — GCC & MENA Intelligence

Respiratory medicine intersects asthma, COPD, interstitial lung disease, allergy immunotherapy, pulmonary hypertension, sleep disordered breathing, and post‑viral fibrotic sequelae clusters accelerated after pandemic waves. Biologic asthma anti‑IgE, anti‑IL5/5R, and anti‑IL4Rα pathways fragment severe eosinophilic phenotypes while triple LAMA/LABA/ICS inhalers dominate maintenance COPD even as dual bronchodilator tenders compress net pricing.